Evaluation of a modified paediatric early warning score for children with congenital heart disease

Simone Commotio1, Nicolas Leister1, Christoph Menzel1

  • 1Department of Anaesthesiology and Intensive Care Medicine, University Hospital Cologne, Cologne, Germany.

Cardiology in the Young
|September 11, 2023
PubMed

Insights

A modified paediatric early warning score effectively identifies clinical deterioration in children with cyanotic congenital heart disease (CHD). This revised system offers improved sensitivity and specificity compared to the original score for this vulnerable population.

Area of Science:

  • Pediatric Cardiology
  • Critical Care Medicine
  • Clinical Monitoring Systems

Background:

  • Paediatric early warning scores (PEWS) are crucial for detecting clinical deterioration in hospitalized children.
  • Existing PEWS often perform poorly in children with cyanotic congenital heart disease (CHD) due to their adaptation to lower arterial oxygen saturation levels.

Purpose of the Study:

  • To compare the efficacy of the original Paediatric European Working Party on Critical Care (PEWSS) score with a modified version tailored for children with cyanotic CHD.

Main Methods:

  • A retrospective, single-center study was conducted in a pediatric cardiology intermediate care unit.
  • The study analyzed the performance of both the original and modified PEWSS in identifying clinical deterioration.

Main Results:

  • The original PEWSS showed a significant shift towards higher scores in cyanotic CHD patients, indicating potential unsuitability.
  • The modified PEWSS demonstrated superior performance in identifying the need for clinical action in cyanotic CHD patients, with higher sensitivity and specificity compared to the original score.
  • Receiver operating characteristic analysis showed improved area under the curve for the modified score in cyanotic CHD patients (0.862 vs. 0.731).

Conclusions:

  • The modified PEWSS provides a uniform and effective scoring system for identifying clinical deterioration in both cyanotic and non-cyanotic pediatric patients.
  • This modification enhances the reliability of PEWS for children with cyanotic CHD, improving patient safety and clinical management.
Abstract